Compare Aventis Pharma with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs FULFORD INDIA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA FULFORD INDIA SANOFI INDIA/
FULFORD INDIA
 
P/E (TTM) x 36.3 398.8 9.1% View Chart
P/BV x 6.5 6.2 104.2% View Chart
Dividend Yield % 1.3 0.1 1,589.3%  

Financials

 SANOFI INDIA   FULFORD INDIA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
FULFORD INDIA
Mar-14
SANOFI INDIA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs6,840942 726.1%   
Low Rs4,630450 1,028.9%   
Sales per share (Unadj.) Rs1,203.1691.4 174.0%  
Earnings per share (Unadj.) Rs165.311.5 1,441.9%  
Cash flow per share (Unadj.) Rs209.915.4 1,366.3%  
Dividends per share (Unadj.) Rs84.002.00 4,200.0%  
Dividend yield (eoy) %1.50.3 509.7%  
Book value per share (Unadj.) Rs963.6380.0 253.6%  
Shares outstanding (eoy) m23.033.90 590.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.81.0 473.5%   
Avg P/E ratio x34.760.7 57.1%  
P/CF ratio (eoy) x27.345.3 60.3%  
Price / Book Value ratio x6.01.8 324.9%  
Dividend payout %50.817.4 291.3%   
Avg Mkt Cap Rs m132,0782,714 4,865.8%   
No. of employees `0003.30.4 743.5%   
Total wages/salary Rs m4,068505 805.5%   
Avg. sales/employee Rs Th8,393.86,073.0 138.2%   
Avg. wages/employee Rs Th1,232.41,137.4 108.3%   
Avg. net profit/employee Rs Th1,153.0100.7 1,145.2%   
INCOME DATA
Net Sales Rs m27,7082,696 1,027.6%  
Other income Rs m897125 715.3%   
Total revenues Rs m28,6052,822 1,013.7%   
Gross profit Rs m6,235-46 -13,437.5%  
Depreciation Rs m1,02715 6,756.6%   
Interest Rs m710 73.7%   
Profit before tax Rs m6,09854 11,230.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,29210 23,875.0%   
Profit after tax Rs m3,80645 8,514.5%  
Gross profit margin %22.5-1.7 -1,307.7%  
Effective tax rate %37.617.7 212.6%   
Net profit margin %13.71.7 828.6%  
BALANCE SHEET DATA
Current assets Rs m15,9221,738 916.0%   
Current liabilities Rs m6,235545 1,144.7%   
Net working cap to sales %35.044.3 79.0%  
Current ratio x2.63.2 80.0%  
Inventory Days Days6448 131.3%  
Debtors Days Days214 484.7%  
Net fixed assets Rs m7,53912 63,352.9%   
Share capital Rs m23039 589.7%   
"Free" reserves Rs m21,9621,443 1,522.0%   
Net worth Rs m22,1921,482 1,497.4%   
Long term debt Rs m00-   
Total assets Rs m29,8392,077 1,436.8%  
Interest coverage x872.16.7 12,986.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.91.3 71.5%   
Return on assets %12.82.6 489.6%  
Return on equity %17.23.0 568.6%  
Return on capital %27.54.3 639.0%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m7,58717 44,110.5%   
Fx outflow Rs m7,145673 1,061.4%   
Net fx Rs m442-656 -67.4%   
CASH FLOW
From Operations Rs m3,73990 4,154.4%  
From Investments Rs m-731105 -698.9%  
From Financial Activity Rs m-1,972-14 13,985.8%  
Net Cashflow Rs m1,036181 574.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 14.4 3.8 378.9%  
FIIs % 14.6 0.1 14,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 21.2 49.5%  
Shareholders   15,184 4,783 317.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   SHASUN PHARMA  WYETH LTD  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 1,028 Points; Oil & Gas, FMCG and Metal Stocks Rally(Closing)

Indian share markets continued to trade in the green during closing hours and ended their day on a strong note, tracking global cues.

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Mar 31, 2020 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - VENUS REMEDIES COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS